Franchise-focused personal fairness agency Franchise Fairness Companions (FEP) introduced it acquired a majority stake in 7 Crew, the second-largest franchisee of the fast-growing U.S. espresso chain 7 Brew.
With the deal, FEP stated it’s following by means of on plans to open greater than 200 7 Brew drive-through areas throughout Texas, Florida, Oklahoma and New Mexico.
Current 7 Crew traders Masked Rider Capital and Crimson Sky Holdings are retaining vital fairness stakes in 7 Crew, which presently operates roughly 50 7 Brew areas, in line with an announcement made by FEP as we speak. The monetary phrases of FEP’s majority-stake funding weren’t disclosed.
7 Brew, which was based by Ron Crume in Northwest Arkansas with a single location, initially providing seven sweetened flavored espresso drinks on its menu, has grow to be the fastest-growing chain within the U.S. over the previous two years, in line with Technomic market studies.
The chain, which is concentrated on quick-service kiosks — typically with a number of drive-through lanes — reported having 14 areas in 2021. As of earlier this 12 months, the corporate stated it had greater than 460 areas.
7 Brew Retailer Counts by State (Prime 10)
State | Shops | Share of Whole |
---|---|---|
Texas | 53 | 16% |
Arkansas | 35 | 11% |
Missouri | 27 | 8% |
Florida | 21 | 6% |
Ohio | 18 | 5% |
Oklahoma | 17 | 5% |
Indiana | 17 | 5% |
Tennessee | 15 | 5% |
Alabama | 15 | 5% |
Kentucky | 13 | 4% |
Different states (mixed) | 100 | 30% |
Final 12 months, the personal fairness agency Blackstone introduced an undisclosed funding in 7 Brew, saying the transfer was designed to speed up retail enlargement together with a number of franchisees.
In June of this 12 months, PE agency Orangewood Companions elevated its investments in one other main 7 Brew franchisee, Motley 7 Brew (M7B), to fund acquisitions and new-unit growth, in line with the agency.
Feedback? Questions? Information to share? Contact DCN’s editors right here. For all the most recent espresso trade information, subscribe to the DCN publication.